These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4806178)

  • 1. [Toxicity and inconveniences of chemotherapy].
    Gino GC
    Cancro; 1973; 26(4):223-30. PubMed ID: 4806178
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical study of antitumor compounds.
    Syrkin AB
    Natl Cancer Inst Monogr; 1977 Mar; (45):255-9. PubMed ID: 927492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effect of antineoplastic agents and its prevention].
    Takemasa Y
    Naika; 1971 Oct; 28(4):685-9. PubMed ID: 4943167
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of antineoplastic agents in the elderly patient.
    Balducci L; Parker M; Sexton W; Tantranond P
    Semin Oncol; 1989 Feb; 16(1):76-84. PubMed ID: 2645652
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical objectives and normal tissue responses in combined chemotherapy and radiotherapy.
    Peckham MJ; Collis CH
    Bull Cancer; 1981; 68(2):132-41. PubMed ID: 7236899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA; Hall TC; Sherman CD; Savlov ED
    Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
    [No Abstract]   [Full Text] [Related]  

  • 7. Hygienic-toxicological aspects of exposure to lead. A critical review.
    Cikrt M; Bencko V
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):343-57. PubMed ID: 6761391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy, toxicity, and the clinician.
    Perry MC
    Semin Oncol; 1982 Mar; 9(1):1-4. PubMed ID: 7071607
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brief notes on the contribution of the immunology laboratory to the chemotherapy department].
    Pinto AS
    Arq Patol; 1973 Apr; 45(1):17-21. PubMed ID: 4588745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late effects of cancer chemotherapy in children].
    Doz F
    Arch Pediatr; 2007 Jun; 14(6):612-4. PubMed ID: 17419018
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged low-dosage administration of hexamethylmelamine (NC 13875).
    Wilson WL; Bisel HF; Cole D; Rochlin D; Ramirez G; Madden R
    Cancer; 1970 Mar; 25(3):568-70. PubMed ID: 5461337
    [No Abstract]   [Full Text] [Related]  

  • 12. The selectivity of effectiveness of cytostatic agents.
    Gerhartz H; Hampel KE
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):283-91. PubMed ID: 5659733
    [No Abstract]   [Full Text] [Related]  

  • 13. Organ-directed toxicology of antitumor agents. Symposium summary.
    Lazo JS; Hacker MP
    Fed Proc; 1985 Apr; 44(7):2335-8. PubMed ID: 4091888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicity criteria].
    Furue H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):616-26. PubMed ID: 7717713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effects of cytostatic diastereomeric dibromhexitols.
    Petrányi G; Nouza K; Szollár J; Institoris L
    Folia Biol (Praha); 1969; 15(5):366-76. PubMed ID: 5344439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect on the organs and blood of experimental animals, body distribution and excretion of the antineoplastic antibiotic tauromycetin].
    Vertogradova TP; Kunrat IA; Muraveĭskaia VS
    Antibiotiki; 1970 Jan; 15(1):59-63. PubMed ID: 5442476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Will transfer of cytostatic drug resistance genes increase hematopoiesis resistance in the treatment of malignant tumors?].
    Jelínek J; Fairbairn LJ; Dexter TM; Rafferty JA; Stocking C; Baum C; Ostertag W; Margison GP
    Cas Lek Cesk; 1997 Jan; 136(1):22-6. PubMed ID: 9147848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preface-importance of supportive therapies against adverse drug reactions in cancer treatment].
    Tsukagoshi S;
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1279-83. PubMed ID: 12146012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of late cardiovascular toxicity from cancer chemotherapy.
    Steingart R
    J Clin Oncol; 2005 Dec; 23(36):9051-2. PubMed ID: 16301591
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
    Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.